tiprankstipranks
Trending News
More News >
SPDR S&P BIOTECH ETF (XBI)
NYSEARCA:XBI
US Market

SPDR S&P BIOTECH ETF (XBI) Price & Analysis

Compare
Followers

XBI Stock Chart & Stats


---

Ownership Overview

4.29%1.45%94.17%
Insiders
1.45% Other Institutional Investors
94.17% Public Companies and
Individual Investors

XBI FAQ

What was SPDR S&P BIOTECH ETF’s price range in the past 12 months?
SPDR S&P BIOTECH ETF lowest stock price was $81.14 and its highest was $105.47 in the past 12 months.
    What is SPDR S&P BIOTECH ETF’s market cap?
    SPDR S&P BIOTECH ETF’s market cap is $6.36B.
      When is SPDR S&P BIOTECH ETF’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were SPDR S&P BIOTECH ETF’s earnings last quarter?
      Currently, no data Available
      Is SPDR S&P BIOTECH ETF overvalued?
      According to Wall Street analysts SPDR S&P BIOTECH ETF’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does SPDR S&P BIOTECH ETF pay dividends?
        SPDR S&P BIOTECH ETF pays a Thriceyearly dividend of $0.005 which represents an annual dividend yield of 0.18%. See more information on SPDR S&P BIOTECH ETF dividends here
          What is SPDR S&P BIOTECH ETF’s EPS estimate?
          SPDR S&P BIOTECH ETF’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does SPDR S&P BIOTECH ETF have?
          Currently, no data Available
          What happened to SPDR S&P BIOTECH ETF’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of SPDR S&P BIOTECH ETF?
          Currently, no hedge funds are holding shares in XBI
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis